15/08/2026
Driven by its core DNA- , Ferozsons Laboratories Limited and BF Biosciences brought together leading endocrinologists, the Vice President of the , healthcare professionals, partners and public figures for an evening focused on how innovation can make metabolic care more informed, connected and accessible.
The event marked the launch of Continuous Glucose Monitoring technology in , bringing real-time glucose insights closer to people living with diabetes and supporting a better understanding of how their glucose responds throughout everyday life.
The conversation went beyond technology. Expert perspectives explored the evolving landscape of , while personal experiences brought the realities of living with —and the needs of patients and their families—to the forefront. Guests also experienced emerging solutions across disease management, diagnosis, awareness and digital care, including the unveiling of the Slim Possible website.
Partnership remained central to this journey—from becoming an affiliate of to collaborating with Meethi Zindagi to help extend access to technology and support for communities where it can make a meaningful difference.
Together, these moments reflected a broader vision for metabolic health: bringing science, technology, partnerships and patient experience together so that innovation ultimately translates into better choices, greater confidence and better everyday lives for patients.
Launching a new era of metabolic care.
Keeping .
CGM - Life in Range
